Study Stopped
The study population is smaller than expected. No subjects were included.
The CRT-KIR Study (Cardiac Resynchronization Therapy [CRT] in the Early Phase After Heart Surgery)
Cardiac Resynchronization Therapy (CRT) in the Early Phase After Heart Surgery
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
In patients with broad QRS complexes on electrocardiogram (ECG), the delayed electrical activation of the left heart chamber will cause abnormal contraction.This has been shown to be possible to treat by a special pacemaker treatment which includes pacing of the left heart chamber (= CRT treatment). In this study the researchers will investigate the effect of acute CRT treatment in the early phase after open heart surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2005
CompletedFirst Posted
Study publicly available on registry
September 19, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedJuly 10, 2007
February 1, 2006
September 11, 2005
July 9, 2007
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Non invasive cardiac output after 72 hours CRT (versus control) treatment
Secondary Outcomes (5)
Echocardiographic measures of left ventricular (LV) function
Mixed venous oxygen saturation
Invasively determined cardiac output
Plasma brain natriuretic peptide (p-BNP)
Number of hours with inotropic treatment
Interventions
Eligibility Criteria
You may qualify if:
- Patient scheduled for open heart surgery (coronary artery bypass graft \[CABG\] or mitral valve surgery or aortic valve surgery or combinations of the above mentioned surgical procedures) and LV ejection fraction \< 35% and bundle branch block (QRS \> 9.12 s)
You may not qualify if:
- Severe right heart failure
- Permanent atrial fibrillation
- Congenital heart disease
- Serious non-cardiac disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jesper H Svendsen, MD
Rigshospitalet, Denmark
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 11, 2005
First Posted
September 19, 2005
Study Completion
September 1, 2008
Last Updated
July 10, 2007
Record last verified: 2006-02